NEW YORK, April 20 (GenomeWeb News) - Nanogen of San Diego and Toronto-based SynX Pharma said today that the Ontario Superior Court of Justice and SynX shareholders have approved Nanogen's all-stock transaction of SynX, which was originally announced in February.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.